Health policy experts pushing for change in feds’ funding for research and development
By Mark BrownleeApr. 25, 2011
Federal and provincial governments currently give pharmaceutical companies tax breaks and subsidies to encourage them to devote more of their budgets to developing new drugs.
Health policy experts are pushing for changes to the federal government’s system of funding the research and development of new pharmaceuticals in the hopes of making drugs that are necessary to patients’ health more affordable.
People. Policy. Politics. This is an exclusive subscriber-only story.
Canada has been without an ambassador in China for five months, during a time when relations with China have deteriorated. Now there’s reports Chinese Ambassador Lu Shaye is set to depart for a new post.